< Back to Find a Trial

Assessment of Safety, Tolerability and Efficacy of LY3303560 in Early Symptomatic Alzheimer’s Disease (18G-MC-LMDC)

ID

NCT03518073

Condition Studied

Alzheimer's Disease

Phase

Phase II

Status

Closed

Intervention

LY3303560

Principal Investigator

Julio Rojas, MD, PhD

[email protected]

Please go to ClinicalTrials.gov for more information.